News Focus
News Focus
Post# of 257559
Next 10
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

Re: RockRat post# 106546

Tuesday, 11/08/2011 12:19:20 AM

Tuesday, November 08, 2011 12:19:20 AM

Post# of 257559
Regado provides additional phase-2b data on RB006/RB007 anticoagulant and reversing agent:

http://finance.yahoo.com/news/Regado-Biosciences-Inc-prnews-3336913480.html?x=0&.v=1

The main results from this phase-2b trial were presented at ACC in Mar 2011 (#msg-61433660).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today